• LAST PRICE
    25.1600
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.0398%)
  • Bid / Lots
    25.1400/ 4
  • Ask / Lots
    25.1700/ 4
  • Open / Previous Close
    25.2500 / 25.1500
  • Day Range
    Low 25.1200
    High 25.2600
  • 52 Week Range
    Low 23.6500
    High 31.7200
  • Volume
    54,544
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 25.15
TimeVolumeSNN
09:32 ET634625.24
09:33 ET262225.205
09:35 ET60025.185
09:37 ET108125.17
09:39 ET327425.18
09:42 ET219825.15
09:44 ET10025.18
09:46 ET300625.185
09:48 ET139025.15
09:50 ET230025.14
09:51 ET30025.15
09:53 ET1419925.14
09:55 ET116025.15
09:57 ET61125.13
10:00 ET20025.13
10:02 ET40025.16
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSNN
Smith & Nephew PLC
10.8B
36.0x
-16.83%
United StatesSOLV
Solventum Corp
12.2B
17.2x
---
United StatesBIO
Bio Rad Laboratories Inc
9.3B
-12.1x
---
United StatesTFX
Teleflex Inc
8.9B
37.9x
+12.49%
United StatesAVTR
Avantor Inc
14.1B
45.6x
---
United StatesMASI
Masimo Corp
9.3B
121.6x
-15.37%
As of 2024-11-26

Company Information

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Contact Information

Headquarters
Building 5, Croxley Park, Hatters LaneWATFORD, United Kingdom WD18 8YE
Phone
207-401-7646
Fax
207-930-3353

Executives

Non-Executive Independent Chairman of the Board
Rupert Soames
Chief Executive Officer, Executive Director
Deepak Nath
Chief Financial Officer, Executive Director
John Rogers
President - Global Operations
Paul Connolly
President - Orthopaedics
Craig Gaffin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$10.8B
Revenue (TTM)
$5.6B
Shares Outstanding
437.2M
Dividend Yield
2.98%
Annual Dividend Rate
0.7500 USD
Ex-Dividend Date
10-04-24
Pay Date
11-08-24
Beta
0.85
EPS
$0.70
Book Value
$11.97
P/E Ratio
36.0x
Price/Sales (TTM)
1.9
Price/Cash Flow (TTM)
11.2x
Operating Margin
8.47%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.